Improved Feasibility & Efficacy of Synthetic DNA for Personalized Cancer Vaccines

Time: 3:00 pm
day: Pre-Conference Focus Day


  • Reviewing key features that make neoantigen anti-cancer vaccines attractive such as their ability to stimulate an immune response that targets the patient’s specific tumor
  • Why personalized neoantigen vaccines have the potential to be more targeted and less toxic compared to traditional cancer treatments, which can often have harmful side effects and are not always effective
  • Evaluating the optimal dose and schedule to ensure that the vaccine is effective without causing unnecessary harm to the patient